Mechanism of Action - The Excitement Blockers
- Glutamate: The primary excitatory neurotransmitter in the CNS. It acts as the brain's main "gas pedal."
- Its overactivity can lead to seizures.
- 📌 Mnemonic: GlutaMATE is an EXCITING guy!
- Key Receptors: Glutamate binds to ionotropic receptors that, when activated, allow positive ions to flow into the neuron, causing excitation.
- AMPA Receptors: Mediate fast synaptic transmission by allowing $Na^{+}$ influx.
- NMDA Receptors: Gate both $Na^{+}$ and $Ca^{2+}$. Require glycine as a co-agonist.

⭐ High-Yield Fact: Beyond seizures, blocking NMDA receptors is crucial for preventing excitotoxicity, the neuronal death caused by prolonged excitatory stimulation, often seen in status epilepticus and stroke.
The Drugs - Rogues' Gallery of Antagonists
- Core Mechanism: Glutamate is the brain's main "on" switch. These drugs work by antagonizing its receptors (NMDA & AMPA), thus dampening neuronal hyperexcitability and stopping seizure propagation.
| Drug | Target | Clinical Use | Key Adverse Effects |
|---|---|---|---|
| Perampanel | AMPA Receptor (non-competitive antagonist) | Focal-onset seizures (adjunctive, with or without secondary generalization), Primary generalized tonic-clonic seizures. | Dizziness, somnolence, headache. ⚠️ Black Box Warning: Serious dose-related psychiatric/behavioral changes (aggression, hostility, homicidal ideation). |
| Felbamate | NMDA Receptor (modulates glycine binding site) | Refractory seizures, particularly in Lennox-Gastaut syndrome. | ⚠️ Black Box Warnings: Aplastic anemia (risk ~1:3,600) and acute hepatic failure. Use is severely restricted. |
| Topiramate | AMPA/Kainate Receptors, VGSCs, GABA-A agonist | Broad-spectrum antiepileptic (focal & generalized), migraine prophylaxis, weight loss. | Cognitive slowing ("Dopamax"), paresthesias, weight loss, metabolic acidosis, nephrolithiasis. |
📌 PERAmpanel causes PERAnoia (psychiatric side effects) by blocking AMPA.
Clinical Use & Cautions - Prescribing Playbook
-
Felbamate
- Use: Reserved for refractory seizures (e.g., Lennox-Gastaut syndrome) due to its risk profile.
- Cautions: ⚠️ Black Box Warnings for aplastic anemia and acute hepatic failure. Requires signed patient consent.
-
Perampanel (AMPA receptor antagonist)
- Use: Adjunctive therapy for focal-onset and primary generalized tonic-clonic seizures in patients aged ≥ 12.
- Cautions: ⚠️ Black Box Warning for serious, dose-related psychiatric and behavioral adverse reactions (e.g., aggression, hostility, homicidal ideation).
-
Topiramate
- Use: Broad-spectrum agent for focal and generalized seizures; also used for migraine prophylaxis.
- Cautions: Can cause cognitive slowing ("Dopamax"), metabolic acidosis, kidney stones, and acute angle-closure glaucoma. Promotes weight loss.
-
Lamotrigine
- Use: Broad-spectrum for focal, generalized, and absence seizures; also a key mood stabilizer in bipolar disorder.
- Cautions: ⚠️ Black Box Warning for serious skin rashes (SJS/TEN).
⭐ The risk of SJS/TEN with Lamotrigine is significantly increased by co-administration with valproate (which inhibits its metabolism) and by rapid dose escalation.
High-Yield Points - ⚡ Biggest Takeaways
- Glutamate antagonists reduce neuronal excitability by blocking the brain's primary excitatory neurotransmitter, targeting AMPA or NMDA receptors.
- Felbamate is reserved for refractory seizures (e.g., Lennox-Gastaut) due to high risks of aplastic anemia and hepatic failure.
- Topiramate also blocks AMPA/kainate receptors; watch for cognitive slowing ("dopiramate"), kidney stones, and metabolic acidosis.
- Perampanel is a selective AMPA antagonist with a black box warning for serious psychiatric and behavioral reactions.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app